Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway

• Ngā kaituhi matua: Xiaoxiao Yuan (Author), Zhaodong Juan (Author), Rui Zhang (Author), Xiaotong Sun (Author), Ru Yan (Author), Feng Yue (Author), Yaru Huang (Author), Jiacheng Yu (Author), Xiaohui Xia (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Our pilot studies have shown that clemastine fumarate (CLE) can protect against myocardial ischemia-reperfusion injury (MIRI) through regulation of toll like receptor 4 (TLR4). However, the protective mechanism of CLE and related signaling pathways for MIRI remains unclear. The objective of this stu...